SG
SpyGlass Pharma, Inc. Common Stock
SGP · NASDAQ
$29.08 -0.58% (-$0.17)
1M +10.74%
Market Cap $972.2M
P/E Ratio -
Div. Yield -
ROE 75.64%
Valuation
48 /100
Fair P/B 4.18x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 23.03%
ROIC 26.54%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 25.06x
Debt/Equity 0.01x
Debt/Assets N/A
Stability
50 /100
Moderate Beta -0.93x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SGP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Patrick H. Mooney
Employees
76
Headquarters
Irvine
Nadcházející události
05 LIS
Earnings
Upcoming earnings report